What You Should Know:
– Nabla, one of the most widely adopted AI assistants in clinical care secures $70M in Series C funding led by HV Capital, with Highland Europe joining as a key investor, alongside DST Global, and existing investors Cathay Innovation, and Tony Fadell’s Build Collective. The funding brings Nabla’s total capital raised to $120M.
– The new capital will accelerate product development, fuel growth across Nabla’s technical and go-to-market teams, and support strategic partnerships to expand its AI assistant into new care settings and deliver impact at a national scale.
From Documentation to Agentic AI
The funding round follows a wave of rapid adoption across U.S. health systems, with Nabla’s AI assistant now embedded in more than 130 healthcare organizations, including major academic medical centers, safety-net hospitals, and physician groups.
Now, Nabla is expanding beyond ambient documentation into a more agentic model of clinical AI. This next phase will enhance clinical documentation integrity (CDI), initiate EHR actions, and adapt across various care settings to support diverse clinical roles. By unifying ambient listening, dictation, coding, and command capabilities into a single extensible platform, Nabla is building toward its long-term vision of a proactive assistant that intuitively streamlines clinical workflows.
Building an Adaptive Agentic Platform
With this new capital, Nabla will build a comprehensive Adaptive Agentic Platform, accelerating the development of several key features:
- Proactive Coding Agent: Improving real-time support for ICD-10, HCC, and MCC coding, with upcoming features to guide E/M coding and surface compliance nudges.
- Context-Aware Agent: Expanding its use of historical data to introduce smarter documentation, initiate orders, and direct EHR commands through an intuitive interface.
- Custom Care Setting Agent: Deploying new capabilities tailored for nurses and other frontline roles, with early expansion into inpatient environments.
“We’re going even deeper into clinical workflows while continuing to offer a highly customizable assistant that works across specialties,” said Alex Lebrun, co-founder and CEO of Nabla. “Clinicians already trust our accuracy and speed, and this funding allows us to expand that impact by embedding intelligent support directly into care delivery.”
Recent Traction/Milestones
Nabla’s assistant is now used by leading systems such as CVS Health, Children’s Hospital Los Angeles, and the University of Iowa Health Care. The company has seen its revenue multiply by five over the past six months and now supports more than 85,000 clinicians and 20 million annual encounters. The platform is delivering measurable results, helping clinicians cut documentation time by more than half. Peer-reviewed studies from the University of Iowa Health Care and real-world data from Denver Health have confirmed significant reductions in clinician burnout and a 15-point increase in patient satisfaction.
